SIRT3 and cardiac hypertrophy: SIRT3‐mediated deacetylation activates enzymes responsible for reducing ROS in protective action against oxidative stress‐dependent phenomena or diseases such as cardiac hypertrophy, aging, cancer, cardiac dysfunction, and neural degeneration.